Teeple, A. and Muser, E. (2017) “Cost Per Responder Analysis of Guselkumab versus Adalimumab using Efficacy Results fromm a Head-to-Head Clinical Trial in Patients with Moderate to Severe Plaque Psoriasis”, SKIN The Journal of Cutaneous Medicine, 1(3.1), p. s6. doi: 10.25251/skin.1.supp.5.